Trial intelligence / Profile preview

Topical recombinant human epidermal growth factor and skin-identical lipid moisturizers for xerosis

KCT0001508Phase 3Completed

Sponsor
CGBio
Start
Dec 2013
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of nepidermin in Asteatosis, sponsored by CGBio. Started Dec 2013; status: completed.

02

Drugs

nepidermin
03

Conditions

Asteatosis

Beyond the preview

Go deeper on KCT0001508.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on KCT0001508.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call